Deletion of exon 4 from human surfactant protein C results in aggresome formation and generation of a dominant negative.
Human surfactant protein C (hSP-C) is synthesized by the alveolar type 2 cell as a 197 amino acid integral membrane proprotein and proteolytically processed to a secreted 3.7 kDa mature form. Although the SP-C null mouse possesses a non-lethal phenotype, a heterozygous substitution of A for G in the first base of intron 4 of the human SP-C gene (c.460+1A>G) has been reported in association with familial interstitial lung disease and absence of mature protein. This mutation produces a splice deletion of exon 4 (deltaExon4) resulting in removal of a positionally conserved cysteine in the C-terminal flanking propeptide. Based on a prior study showing that an identical deletion in the rat isoform diverted mutant protein to stable aggregates, we hypothesized that expression of the deltaExon4 mutation would result in disruption of intracellular trafficking of both mutant and wild-type proSP-C. We tested this in vitro using fusion proteins of EGFP conjugated either to wild-type SP-C (EGFP/hSP-C(1-197)) or to SP-C deleted of Exon4 (EGFP/hSP-C(deltaExon4)). Fluorescence microscopy showed that EGFP/hSP-C(1-197) transfected into A549 cells was expressed in a punctuate pattern in CD63 (+) cytoplasmic vesicles, whereas EGFP/hSP-C(deltaExon4) accumulated in ubiquitinated perinuclear inclusions linked to the microtubule organizing center. A similar juxtanuclear pattern was observed following transfection of SP-C cDNA lacking only cysteine residues in the C-terminal propeptide encoded by Exon 4 (EGFP/hSP-C(C120/121G)). To evaluate whether mutant proSP-C could function as a dominant negative, EGFP/hSP-C(deltaExon4) was cotransfected with HA-tagged hSP-C(1-197) and resulted in the restriction of both forms to perinuclear compartments. Addition of Na(+) 4-phenylbutyrate, a facilitator of trafficking of other misfolded proteins, attenuated the aggregation of EGFP/hSP-C(deltaExon4). We conclude that c.460+1A>G mutation of human SP-C results in disruption of disulfide-mediated folding encoded by Exon 4 leading to diversion of unprocessed proSP-C to aggresomes. The heterotypic oligomerization of hSP-C(1-197) and hSP-C(deltaExon4) provides a molecular mechanism for the dominant-negative effect observed in vivo.
Wang
Wen-Jing
WJ
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Mulugeta
Surafel
S
Russo
Scott J
SJ
Beers
Michael F
MF
D002451:Cell Compartmentation / Q000235:genetics; D022162:Cytoplasmic Vesicles / Q000235:genetics / Q000378:metabolism; D004220:Disulfides / Q000378:metabolism; D005091:Exons / Q000235:genetics; D017353:Gene Deletion; D006801:Humans; D002479:Inclusion Bodies / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D036341:Intercellular Signaling Peptides and Proteins; D022101:Microtubule-Organizing Center / Q000473:pathology; D009154:Mutation / Q000235:genetics; D010455:Peptides / Q000235:genetics / Q000378:metabolism; D010654:Phenylbutyrates / Q000494:pharmacology; D017510:Protein Folding; D021381:Protein Transport / Q000187:drug effects / Q000235:genetics; D011650:Pulmonary Alveoli / Q000378:metabolism*; D037721:Pulmonary Surfactant-Associated Protein C / Q000172:deficiency* / Q000235:genetics; D011663:Pulmonary Surfactants / Q000378:metabolism; D011993:Recombinant Fusion Proteins; D020545:Respiratory Mucosa / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D025801:Ubiquitin / Q000378:metabolism
D004220:Disulfides; D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; D010654:Phenylbutyrates; D037721:Pulmonary Surfactant-Associated Protein C; D011663:Pulmonary Surfactants; D011993:Recombinant Fusion Proteins; C489679:SFTPC protein, human; C489680:Sftpc protein, mouse; D025801:Ubiquitin; C075773:4-phenylbutyric acid